Yvonne Dong

Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis

P. Moreau, Kihyun Kim, Jin Seok Kim, 2021, International Journal of Hematology.

AMEERA-4: A preoperative window-of-opportunity (WOO) study to assess the pharmacodynamic (PD) activity of amcenestrant or letrozole in postmenopausal patients with ER+/HER2− primary breast cancer.

M. Campone, Lei Wang, C. Herold, 2022, Journal of Clinical Oncology.

Phase 1b Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed, Transplant-ineligible Multiple Myeloma Patients

S. Bringhen, E. Ocio, J. San-Miguel, 2023, HemaSphere.